James McKiernan, M.D.
Dr. McKiernan graduated from Johns Hopkins University in 1989 with a B.A. in Biology and received his medical degree from Columbia University College of Physicians and Surgeons in 1993. He has remained affiliated with NewYork-Presbyterian/Columbia University Medical Center for the past 22 years, completing his training in urology and generalat the Medical Center in 1999. Dr. McKiernan then completed a two-year urologic surgical oncology fellowship studying at Memorial Sloan-Kettering Cancer Center.
In 2001 Dr. McKiernan was appointed as Assistant Professor of Urology at Columbia University College of Physicians & Surgeons. In 2006 Dr McKiernan was named to the John and Irene Given endowed Chair in Urology and in 2007 was named Associate Professor of Clinical Urology and . In 2010 Dr McKiernan was promoted to Professor of Clinical Urology and has served as the Vice Chairman of Urology and Director of Urologic Oncology since 2006.
Dr. McKiernan is actively involved in research and discovery with ongoing programs focused on improving patient clinical outcomes with. His research and discoveries have been published in Urology, Journal of Urology, Journal of Clinical Oncology, Urologic Oncology, British Journal of Urology, Cancer, and Cancer Research. He has authored and co-authored more than 135 scientific articles and book chapters in the field of Urologic Oncology. For the past 10 years he has directed the research efforts at Columbia University in outcomes and effectiveness research in urologic cancer . In addition, Dr. McKiernan directs the experimental clinical trials program in therapy for drug resistant . This program has helped develop promising new agents for bladder preservation in patients whose cancer has recurred after the use of BCG therapy. In collaboration with the research scientists in the Herbert Irving Comprehensive Cancer Center this team continues to develop new therapeutic strategies for managing .
Click here for more information.